Est. 2001·3,000+ placements · six offices · four regions

Company signals · Biotech & Pharma

WuXi Biologics

1 signal in the current window, with MitchelLake's leadership read on each.

Last updated

Market context: The wider read — a Talent Market Index of 104.6 (Hot), up 3.6 month-on-month — shows Asia signal flow steady (+1.1pts).

WuXi Biologics: 1 signal in the last 90 days — in line with the Biotech & Pharma median of 1 across 33 tracked companies.

Signals at WuXi Biologics

WuXi Biologics signals in the last 90 days

1 public signal observed since 5 August 2026, by type.

More signals across Biotech & Pharma

Partnership · Asia

Gilead Sciences →

Gilead agreed to pay Shanghai-based PepStar Therapeutics US$1.275B upfront for global rights to HCXT-2001, an experimental oral IL-23 receptor inhibitor in Phase I, as a licensing deal that strengthens its IBD pipeline.

Partnership · Asia

Bora Pharmaceuticals →

Bora Pharmaceuticals signed partnership with Insilico Medicine for AI drug discovery. Company launched group-wide AI in Manufacturing program (BORA AIM) to improve process efficiency across sites.

Partnership · Asia

Bristol Myers Squibb →

Bristol Myers Squibb partners with China's Hengrui Pharma on a $15.2 billion deal to advance more than a dozen early-stage drugs

Product Launch · Asia

Biogen →

Biogen's monoclonal antibody felzartamab received first global approval in China for second-line multiple myeloma treatment, in combination with lenalidomide and dexamethasone.

Product Launch · Asia

Celltrion →

Celltrion achieved record quarterly earnings (1.4 trillion won / $950M in sales, 451.8B won operating profit) driven by growing sales of newer biosimilar portfolio and improved manufacturing efficiency. YoY sales growth of 45% and operating profit growth of 86.3%.

M&A Activity · Asia

Torrent Pharmaceuticals →

NCLT (National Company Law Tribunal) approved Torrent Pharma acquisition of JB Chemicals; merger scheme to take effect after Registrar of Companies filing

Where WuXi Biologics's market lands in our work

Weekly briefing

Track companies like WuXi Biologics — with our analysis

Anyone can set an alert for one company. We send a weekly read on the whole peer set — who's moving, and what it means for leadership. Pick what to follow:

Intelligence powered by Autonodal ↗

Nearby in the record

MitchelLake is a global executive search and advisory firm covering AI, innovation and expansion leadership for companies navigating transformation and change across industries, from startups and scale-ups to private-equity-backed and enterprise organisations. 3,000+ C-suite, specialist and board placements since 2001.

Data period
2 Nov 2026 – 2 Nov 2026 · 1 signals for this company
Publisher
MitchelLake

Last updated